Phospholipase A2 [EC 3.1.1.4] (PL-A2) catalyses the hydrolysis of the fatty acid ester bonds at the 2-position of phospholipids liberating the corresponding free fatty acid and lysophosphatidel). This enzyme has recently received much attention because arachidonic acid released by the reaction is the rate-limiting precursor of inflammatory mediators such as prostaglandins and leukotrienes2). It is also reported to play an important role in the pathogenesis of acute pancreatitis3).
As reported in this paper, PL-A2, depending on sources, differ in specificity to inhibitors. Thus,
we searched for new PL-A2 inhibitors in culture filtrates of microorganisms.
In this communication we report the taxonomy, production, isolation, and characterization of the inhibitors, plipastatins Al, A2, B1 and B2.
Materials and Methods

Chemicals
Chemicals employed were as follows: Silica gel 60, Silanised silica gel 60 and TLC-plate Silica gel F254 (0.25 mm thickness) from E. Merck, Darmstadt, FRG; packed column of Nucleosil 5018 from Senshu Scientific Co., Tokyo, Japan; dipalmitoyl phosphatidylcholine (DPC) from Sigma Chemical Co., St. Louis, U.S.A.; [dipalmitoyl-l-14C]DPC, [choline-methyl-14C]DPC and a scintillator Aquasol-2 from New England Nuclear, Boston, U.S.A. All other chemicals were of analytical grade. Enzymes Phospholipases A2 (hog pancreas, 700 u/mg; bee venom, 2,400 u/mg; Crotalus durissus, 200 u/mg) and phospholipase D (cabbage, 0.3 u/mg) were purchased from Boehringer Mannheim, Mannheim, FRG. Phospholipase C (Clostridium perfringens, 1 -2 u/mg) was from Calbiochem-Behring Co., La Jolla, U.S.A.
Microorganism Strain BMG302-fF67 was isolated from a soil sample collected in the premises of Institute of Microbial Chemistry, Shinagawa-ku, Tokyo and has been deposited in the Fermentation Research Institute, Agency of Industrial Science and Technology, Ministry of International Trade and Industry, Tsukuba, Japan under the accession number FERM-P7843.
Taxonomic Characterization
The strain was cultured at 30°C for 7 days on media which were commonly used for taxonomic studies of bacteria. The identification was made from descriptions in BERGEY'S Manual of Determinative Bacteriology 8th Ed.4), Manual for Identification of Medical Bacteria 2nd Ed.n and Taxonomy and Identification of Microorganisms').
Production of Plipastatins
Spores of the strain BMG3O2-fF67 were inoculated into 110 ml of a production medium consisted of glycerol 2.5 %, meat extract 0.5 %, Polypeptone 0.5 %, yeast extract 1.0%, NaCl 0.2%, MgSO4.7H2O 0.05 %, K2HPO4 0.05 % and CaCO3 0.32 % (pH 7.4) in a 500-m1 Erlenmeyer flask, and cultured at 27°C for one day on a rotary shaker (180 rpm). One milliliter of the above seed culture was transferred to 120 ml of the same medium in a 500-ml Erlenmeyer flask and cultured for approximately 20 hours under the same conditions.
Isolation of Plipastatins
The inhibitors produced in the culture filtrate were adsorbed on an Amberlite XAD-7 column (10 % filtrate), after washing the column with H2O (x 5 column), the inhibitors were eluted with 80% MeOH (x 3 column). The active eluate was concd under reduced pressure to dryness and the residue was extracted with MeOH. The extract was concd to give a brown crude powder. A solution of this crude powder in propanol (x 4 v/w powder) was passed through a propanol-filled column of silica gel (x 20 w/w powder). This was followed by successive elution with propanol (x l column), 90 % propanol (x 2 column) and 80 % propanol (x 2.5 column) to collect the fractions containing the active substances, which were then concd to dryness. A brown powder containing plipastatins B1 and B2 (fraction B) was obtained from the 90 % propanol eluate, and a second brown powdered fraction containing plipastatins Al and A2 (fraction A) was obtained from the 80% propanol eluate.
The powder of fraction A was chromatographed on a column of Silanised silica gel (x 100 w/w powder) with a 6 : 4 mixture of MeOH and acetate buffer (1 % potassium acetate plus 3 % acetic acid, pH 5), and on a Sephadex LH-20 column (2.5 x 120 cm) with 80 % MeOH, successively. The active eluate was concd under reduced pressure to give a pale yellow powder (plipastatin A group). This preparation appeared a single spot on silica gel TLC plate as shown in Table 3 . The preparation was further separated into two fractions by a reverse phase HPLC using a Nucleosil 5C18 column (2 x 30 cm, flow rate 8 ml/minute, detection at 254 nm, using Waters ALC/GPC 200 system) with a 1: 1 mixture of MeCN and acetate buffer (2 % potassium acetate plus 6 % acetic acid, pH 4). The respective fractions designated as plipastatins Al and A2 in the order eluted were coned to dryness. The resulting residues were passed through Sephadex LH-20 columns with 80 % MeOH to remove potassium acetate, thereby giving plipastatins Al and A2 as colorless amorphous powders of their potassium salts.
The powder of fraction B obtained from the 90 % propanol eluate by the silica gel column chromatography as described above was rechromatographed on a column of Silanised silica gel (x 100 w/w powder) with a stepwise elution using 40 % MeOH (x 7 column) and 60% MeOH (x 7 column), and a Sephadex LH-20 column (2.5 x 120 cm) with 80 % MeOH, successively. The active eluate was coned to give a pale yellow powder (plipastatin B group). This preparation also showed a single spot by silica gel TLC (Table 3 ), but it was likewise separated into two fractions by a reverse phase HPLC (Nucleosil 5C18, a 65: 35 mixture of the same ingredients presented above). The respective fractions designated as plipastatins B1 and B2 in the order eluted were then coned and applied on Sephadex LH-20 columns in the same manner outlined above to give plipastatins B1 and B2 as colorless amorphous powders of their potassium salts.
Assay for Phospholipase (PL)7) and Inhibitory Activity The reaction mixture (total 0.5 ml) for PL-A2 assay consisted of 50 mm Tris-HCl (pH 7.0), 1 mM CaC12, 0.2 mm DPC which was sonicated at 70" 80°C for 5 minutes with [dipalmitoyl-1-14C]DPC (5 x 104 dpm), PL-A2 (0.01 -0.04 ug-protein) and an inhibitor. The enzyme reaction was started by the addition of the enzyme, following incubation at 37°C for 20 minutes, and stopped by the addition of 1.5 ml of CHCl3 -MeOH (2: 1) and 1.0 ml of 50% MeOH containing 0.1 M potassium chloride and VOL. XXXIX NO. 6 THE JOURNAL OF ANTIBIOTICS 0.1 M sodium carbonate (pH 11). After mixing for 10 seconds with a Vortex-Genie mixer and centrifugation at 3,000 rpm for 5 minutes, the radioactivity of upper phase (1.5 ml) was counted with a scintillator (Aquasol-2, 5 ml). The reaction mixture (total 0.5 ml) for PL-C assay consisted of 50 mM Tris-HCl (pH 7.0), 1 mM CaCl2, 0.2 mm DPC sonicated with [choline-methyl-14C]DPC (4.4 x 104 dpm), PL-C (0.2'-0.5 ug-protein) and an inhibitor. For PL-D assay, 50 mm Tris-HCl (pH 5.6), 1 mm CaCl2, 0.2 mM DPC sonicated with [coline-methyl-14C]DPC (4.4 x 104 dpm) and PL-D (10 ti 20 rig-protein) were used. After incubation at 37°C for 20 minutes, the enzyme reaction was stopped by the addition of 1.5 ml of CHCl3 -MeOH -conc HCl (2: 1: 0.02) and 1.0 ml of 50% MeOH containing with 0.1 M potassium chloride. The radioactivity of upper phase (1.5 ml) was counted by the same procedure mentioned above.
The percent inhibition was calculated by the formula (A-B)/A x 100, where A is dpm of liberated radioactive product by the enzyme in the system without an inhibitor and B is that with an inhibitor. IC,0 value shows the concentration of inhibitor at 50% inhibition of enzyme activity.
Physico-chemical Properties Melting points were taken using a Yanaco MP-S3 apparatus and are uncorrected. UV spectra were recorded on a Beckman DU-8 spectrophotometer, and IR spectra on a Hitachi 260-10 spectrophotometer. Optical rotations were measured on a Perkin-Elmer 241 polarimeter. Mass spectra were obtained on a Hitachi M-80H mass spectrometer.
Hydrolysis of Plipastatin and Analysis of Amino Acids Each plipastatin was hydrolyzed at 105°C for 24 hours with constant boiling hydrochloric acid in a sealed tube. The hydrolysate was obtained by evaporation with H2O to remove hydrochloric acid and analyzed on a Hitachi 835 automatic amino-acid analyzer. The cultivation was performed at 30°C for 7 days unless otherwise specified. The taxonomic characteristics of the strain BMG302-fF67, from which the strain was identified as Bacillus cereus, are described below. Culture Characteristics: Nutrient agar colonies (30°C, 1 -7 days) were dull, opaque, substantially circular and had a irregular, root-like periphery. Wrinkles appeared on the surface of the colonies with age. No diffusible pigment was observed. On nutrient agar slant (30°C, 1 -7 days), the growth was moderate, filiform, opaque, dull, pale yellowish brown; the surface was smooth (1 day), changing to dull with wrinkles after 3 days. In nutrient broth (30°C, 1 -7 days), the growth was moderate, and pellicles were observed on the surface of the tube (1 day). Some sediment was present (5 days). Physiological characteristics of the producing strain BMG302-fF67 are listed in Table 1 The above characters indicated that this strain should belong to Bacillus cereus or Bacillus coagulans.
The comparison of the characteristics of the strain BMG302-fF67 with those of B. cereus4) and B.
coagulans4) is shown in Table 2 . As shown in the table, the strain BMG302-fF67 did not grow at 50°C.
It is more closed to B. cereus than B. coagulans in its positive hydrolysis of gelatin and growth on the medium containing 7 % NaCl. Therefore, we concluded that the strain BMG302-fF67 should be classified as a strain of B. cereus. 1KA; 1 % KOAc+3 % AcOH, 2KA; 2% KOAc+6% AcOH.
Production and Isolation of Plipastatins
The strain of B. cereus BMG302-fF67 was cultured in Erlenmeyer flasks at 27°C for 6 days on a rotary shaker. The time course of the production is shown in Fig. 1 . The maximum peak of plipastatin production in the flasks was obtained at one day, thereafter the production slowly decreased with a pH change to alkaline. 
Physico-chemical Properties
The physico-chemical properties of plipastatins potassium salts are summarized in Table 3 .
The molecular weight and formula of plipastatins were determined by secondary ion mass spectrometry (SI-MS) and the calculation from the contents of the fatty acid and amino acid residues. The UV spectra of all plipastatins were similar and showed an absorption maximum at 276 nm. A UV spectrum of plipastatin Al in The inhibitory activities of plipastatins on phospholipases are shown in Table 4 . All plipastatins inhibited not only phospholipase A2 but also phospholipases C and D at the range of 1.3 to 3.5 x 10-8 M.
No significant inhibition was observed with bee and snake venom PL-A2 preparations.
Plipastatins at 100,ug per ml had no antimicrobial activity except against Corynebacterium bovis 1810 (MIC: 6.25 ug/ml). Intraperitoneal injection of 0.1 mg per mouse of plipastatin Al or B1 slightly suppressed delayedtype hypersensitivity; T/C was 49 % and 58 %, respectively. In vitro, plipastatin Al at 100 ug per ml suppressed the ConA-stimulated T-lymphocyte blastogenesis and the LPS-stimulated B-lymphocyte blastogenesis; T/C was 52% and 15%, respectively. The acute toxicity (LD50 values) of plipastatin Al in mice is as follows: 250-500 mg/kg (ip) and 200-400 mg/kg (iv).
